Xenon Pharmaceuticals (XENE) had its price target raised by Needham & Company LLC from $55.00 to $58.00. They now have a "buy" rating on the stock.
Xenon Pharmaceuticals (XENE) had its price target raised by Wells Fargo & Company from $48.00 to $49.00. They now have an "overweight" rating on the stock.
Xenon Pharmaceuticals: Q4 Earnings Snapshot [Yahoo! Finance]
Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update
Xenon Pharmaceuticals Stock Scores RS Rating Upgrade [Yahoo! Finance]